These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 15783240)

  • 1. Benefit-risk assessment of zaleplon in the treatment of insomnia.
    Barbera J; Shapiro C
    Drug Saf; 2005; 28(4):301-18. PubMed ID: 15783240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zaleplon: a review of its use in the treatment of insomnia.
    Dooley M; Plosker GL
    Drugs; 2000 Aug; 60(2):413-45. PubMed ID: 10983740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon.
    Terzano MG; Rossi M; Palomba V; Smerieri A; Parrino L
    Drug Saf; 2003; 26(4):261-82. PubMed ID: 12608888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group.
    Hedner J; Yaeche R; Emilien G; Farr I; Salinas E
    Int J Geriatr Psychiatry; 2000 Aug; 15(8):704-12. PubMed ID: 10960882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of zaleplon in the treatment of insomnia.
    Israel AG; Kramer JA
    Ann Pharmacother; 2002 May; 36(5):852-9. PubMed ID: 11978165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
    Elie R; Rüther E; Farr I; Emilien G; Salinas E
    J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically important drug interactions with zopiclone, zolpidem and zaleplon.
    Hesse LM; von Moltke LL; Greenblatt DJ
    CNS Drugs; 2003; 17(7):513-32. PubMed ID: 12751920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia.
    Weitzel KW; Wickman JM; Augustin SG; Strom JG
    Clin Ther; 2000 Nov; 22(11):1254-67. PubMed ID: 11117652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia.
    Heydorn WE
    Expert Opin Investig Drugs; 2000 Apr; 9(4):841-58. PubMed ID: 11060714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Zaleplon Clinical Study Group.
    Fry J; Scharf M; Mangano R; Fujimori M
    Int Clin Psychopharmacol; 2000 May; 15(3):141-52. PubMed ID: 10870872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies.
    Rosenberg RP
    Ann Clin Psychiatry; 2006; 18(1):49-56. PubMed ID: 16517453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of zaleplon at peak plasma levels.
    Mangano RM
    Int J Clin Pract Suppl; 2001 Jan; (116):9-13. PubMed ID: 11219331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of insomnia with zaleplon, a novel sleep medication.
    Doghramji PP
    Int J Clin Pract; 2001 Jun; 55(5):329-34. PubMed ID: 11452683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of insomnia--the role of zaleplon.
    Richardson GS; Roth T; Kramer JA
    MedGenMed; 2002 Mar; 4(1):9. PubMed ID: 11965211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Main neuroendocrine features and therapy in primary sleep troubles.
    Amihăesei IC; Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):862-6. PubMed ID: 23272543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, randomized, comparative study to evaluate the efficacy and safety of zaleplon versus zolpidem in shortening sleep latency in primary insomnia.
    Huang YS; Hsu SC; Liu SI; Chen CK
    Chang Gung Med J; 2011; 34(1):50-6. PubMed ID: 21392474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-benzodiazepines for the treatment of insomnia.
    Wagner J; Wagner ML
    Sleep Med Rev; 2000 Dec; 4(6):551-581. PubMed ID: 12531036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review.
    Allain H; Bentué-Ferrer D; Polard E; Akwa Y; Patat A
    Drugs Aging; 2005; 22(9):749-65. PubMed ID: 16156679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis.
    Dündar Y; Dodd S; Strobl J; Boland A; Dickson R; Walley T
    Hum Psychopharmacol; 2004 Jul; 19(5):305-22. PubMed ID: 15252823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zopiclone and zaleplon vs benzodiazepines in the treatment of insomnia: Canadian consensus statement.
    Montplaisir J; Hawa R; Moller H; Morin C; Fortin M; Matte J; Reinish L; Shapiro CM
    Hum Psychopharmacol; 2003 Jan; 18(1):29-38. PubMed ID: 12532313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.